Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxib
about
Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentationAction at a distance: mutations of peripheral residues transform rapid reversible inhibitors to slow, tight binders of cyclooxygenase-2.Substrate-selective Inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide ToneThe endocannabinoid system as a target for novel anxiolytic drugs.
P2860
Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxib
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Exploring the molecular determ ...... yclooxygenase-2 by lumiracoxib
@ast
Exploring the molecular determ ...... yclooxygenase-2 by lumiracoxib
@en
Exploring the molecular determ ...... yclooxygenase-2 by lumiracoxib
@nl
type
label
Exploring the molecular determ ...... yclooxygenase-2 by lumiracoxib
@ast
Exploring the molecular determ ...... yclooxygenase-2 by lumiracoxib
@en
Exploring the molecular determ ...... yclooxygenase-2 by lumiracoxib
@nl
prefLabel
Exploring the molecular determ ...... yclooxygenase-2 by lumiracoxib
@ast
Exploring the molecular determ ...... yclooxygenase-2 by lumiracoxib
@en
Exploring the molecular determ ...... yclooxygenase-2 by lumiracoxib
@nl
P2860
P50
P921
P1476
Exploring the molecular determ ...... yclooxygenase-2 by lumiracoxib
@en
P2093
Lawrence J Marnett
Pieter L Valk
P2860
P304
P356
10.1016/J.BMCL.2013.08.097
P407
P577
2013-09-06T00:00:00Z